Drug disposition in the late preterm ("near-term") newborn

Area of Science:

• Neonatal pharmacology
• Pediatric drug development
• Clinical pharmacy

Background:

• Late preterm newborns frequently require potent medications.
• Drug disposition in this population is often immature compared to term newborns.
• This immaturity stems from biological immaturity.

Purpose of the Study:

• To highlight the need for better understanding of drug disposition in late preterm infants.
• To emphasize the pharmacokinetic challenges in this specific neonatal group.
• To advocate for detailed studies on drug absorption, distribution, metabolism, and elimination.

Main Methods:

• Systematic analysis of pharmacokinetic principles (ADME).
• Developmental pharmacokinetic studies.
• Examination of drug disposition patterns over time.

Main Results:

• Drug disposition in late preterm infants is generally immature.
• Pharmacokinetic maturation does not follow linear or predictable patterns with age.
• Specific pathways of drug disposition require detailed investigation.

Conclusions:

• Inadequate study of drug disposition in late preterm newborns poses risks.
• Non-linear and unpredictable maturation necessitates individualized drug therapy approaches.
• Detailed research into specific drug disposition pathways is essential for safe and effective neonatal drug therapy.